Navigation Links
UCSD study clarifies insulin's role in blocking release of energy in patients with type II diabetes

Chronically high levels of insulin, as is found in many people with obesity and Type II diabetes, may block specific hormones that trigger energy release into the body, according to researchers at the University of California, San Diego (UCSD) School of Medicine. Their findings, which may point to new approaches to developing improved treatment options for the disease, will be published in the September 22 issue of the journal Nature.

The research team, led by Roger Y. Tsien, professor in UCSD’s Departments of Pharmacology and Chemistry and Biochemistry and a Howard Hughes Medical Institute investigator, found that high levels of insulin can block stress hormones known as catecholamines, which normally cause the release of cellular energy. Adrenaline is the best known example of a catecholamine. For normal metabolism to occur, the body needs a balanced input of insulin and catecholamines. One of the actions of insulin --, the main energy storage hormone, is to block activation of the protein kinase A (PKA) enzyme. After a meal, insulin levels go up, and the body stores energy primarily as triglycerides, or fat, in adipose tissue to be used later. When energy is needed, catecholamine triggers activation of PKA, and energy is released. But in people with Type II diabetes, the hormonal balance has been thrown off, because the body continues to produce and store more triglyceride instead of breaking down the fat as released energy.

“Somehow, insulin knows how to specifically block catecholamine-induced PKA, but not other molecules,?said Christopher Hupfeld, assistant professor of Medicine in the UCSD Division of Endocrinology and Metabolism and a co-author of the paper. “When the body has a constantly high level of insulin, this energy- release stimulus is lost.?/p>

The team’s findings provide new understanding to the cause and effect occurring when insulin levels are too high. It also underscores the goal of physicians to bring down insulin levels in
'"/>

Source:UCSD


Page: 1 2

Related biology news :

1. Bioartificial kidney under study at MCG
2. W.M. Keck Foundation funds study of friendly microbes
3. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
4. Genome-wide mouse study yields link to human leukemia
5. Clam embryo study shows pollutant mixture adversely affects nerve cell development
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Same mutation aided evolution in many fish species, Stanford study finds
8. Sequencing of marine bacterium will help study of cell communication
9. Genetically modified rice in China benefits farmers health, study finds
10. A new study examines how shared pathogens affect host populations
11. NYU study reveals how brains immune system fights viral encephalitis

Post Your Comments:
(Date:11/24/2009)...K (November 24, 2009) -- The Wildlife Conservation...that the last remaining population of Siberian tig...ising tide of poaching and habitat loss. , ...n officials of what needs to be done to protect re..., The report was released by the Sibe...
(Date:11/24/2009)...ble in Spanish . , The presence of increase...atory substances in the blood, hinders the loss an...ch project of the University of Navarra conducted ...hool of Pharmacy. , The project, entitled "A nut...e control of body weight and inflammation," examin...
(Date:11/23/2009)... 2009 - The time of day matters to forest trees de...ced by a research team led by Professor Malcolm Ca...rincipal for research and colleagues in the depart... campus. , Capitalizing on their previous work...arch team examined how poplar trees use their 45,0...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2It can be predicted the reaction obese patients will have to a diet 2Time of day matters to thirsty trees, U of T researcher discovers 2Senators Kohl and Feingold Vote to Protect Americas Kids From Tobacco 48691 1Senators Kohl and Feingold Vote to Protect Americas Kids From Tobacco 48691 2Senators Baucus and Tester Vote to Protect Americas Kids From Tobacco 48688 1Senators Baucus and Tester Vote to Protect Americas Kids From Tobacco 48688 2Senators Levin and Stabenow Vote to Protect Americas Kids from Tobacco 48685 1Senators Levin and Stabenow Vote to Protect Americas Kids from Tobacco 48685 2
...d on the messages it receives from its genome. Som...d in most cell types these delayed messages are st...dies (processing bodies). P bodies in worm egg cel...a paper by Boag et al. to be published in the Aug ...separate study Noble et al. report that worm eggs ...
...., a fully,integrated critical care biotherapeutic...Drug Administration (FDA) has granted orphan drug ... the reduction of the incidence and,severity of de...solid organ,transplantation., Ralf Rosskamp, M.D....ment for Ikaria, commented, "The designation of or...
... variants responsible for body shape. Based on wor...ch published today in the open access journal BMC...an LAMA5 gene as a key determinant of weight. , A...blems continues to increase worldwide, there is co...c mechanisms that control fat storage. Maria De Lu...
Other Biology News:Ikaria(R) Receives FDA Orphan Drug Designation for Inhaled Carbon Monoxide for Delayed Graft Function in Solid Organ Transplants 2
(Date:11/24/2009)...JAVIK, Iceland, November 24 /PRNewswire-FirstCall/...nounced the approval of all of its,"first day" mot... of Delaware,(the "Bankruptcy Court"). deCODE last...Chapter 11 of the United States Bankruptcy Code wi...ued by the Bankruptcy Court allow the company to c...
(Date:11/24/2009)...ewswire/ -- Blue Marble Energy Corp. announced tod...ent Authority (OPDA) were recently awarded $2 mill...alization Board (CERB) in a private/public partner...hemical biorefinery in Lincoln County, WA. ,,...elopment of our biorefinery and bring over 70 gree...
(Date:11/24/2009)... 24 Shire plc (LSE: SHP,...eutical company, today,announced that it has submi...laglucerase alfa, the company,s enzyme replacement...1 Gaucher disease. This is the third marketing,app...itted, with previous,submissions in the United Sta...
(Date:11/24/2009)... Connects Customers with Partners Validated to Pro...k Products , Ottawa, ON (...ng provider of products for biological sample coll...nced its new global partner program. The program o...artner community and is designed to help partners ...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
... Alba Therapeutics Corporation,today announced th...cutive,Officer (CEO) and a member of its Board of ...V Life Sciences Advisors, LLC. Previously, he serv...ment team for several,successful entrepreneurial h...ostic and service areas including The Little Clini...
...A policy comment in Science,today quotes Genelex o...ims about the utility of CYP450,testing for partic...macogenetic testing is "required to effectively pr...ssional/paxil.html )., The actual statement is:, ... Pharmacogenetic,testing of this pathway serves as...
...reement to Produce Reference Standard Reagents to ...EWARK, Del., April 3, 2008 Strategic,Diagnostics ...anced antibody,products and services to the life s...ed by Science Applications International Corporati...ibodies for the Proteomics Reagents &,Resources co...
Other Biology Technology:Alba Therapeutics Announces Appointment of Bruce A. Peacock as its Chief Executive Officer 2Science Fuels DNA Testing Controversy with Prejudicial Misquote 2Strategic Diagnostics Inc. Selected as Key Supplier to SAIC-F and the National Cancer Institute for the Development of a Comprehensive Portfolio of Antibodies for Use in Cancer Research 2Strategic Diagnostics Inc. Selected as Key Supplier to SAIC-F and the National Cancer Institute for the Development of a Comprehensive Portfolio of Antibodies for Use in Cancer Research 3
Rabbit Anti-Human ADAMTS16 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human Actopaxin, phospho (Ser8) Monoclonal Antibody, Unconjugated, Clone J160-366 from BD Biosciences Pharmingen
Mouse Anti-Hamartin Monoclonal Antibody, Unconjugated, Clone 1B2 from Cell Signaling Technology
Mouse Anti-Mouse Ly 6C.2(Ly 28.2) Monoclonal Antibody, Unconjugated, Clone 5075-3.6 from CEDARLANE Laboratories Limited
Biology Products: